Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IVVD · against 194 other Healthcare companies of similar size
Ranked #127 of 195 · scores higher than 9% of peers
Bars: peers in each 10-point band of the valuation score69 peers with a valuation score of 0–9, including IVVD · Click a bar to see the companies
Mainly because of its EBITDA yield, free cash flow yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | IVVD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 177 reported | -56.7% | -6.1% | 18% | 30% | |
| EBITDA yieldHigher is better · 203 reported | -563.4% | 1.3% | 5% | 50% | |
| Free cash flow yieldHigher is better · 126 reported | -63.9% | -14.4% | 15% | 20% | |
| Book yieldHigher is better · 184 reported | 105.5% | 65.9% | 67% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 127 | 238M USD | 8 | 41 | |
| 127 | 172M USD | 8 | 3 | |
| 127 | 275M USD | 8 | 46 | |
| 127 | 327M USD | 8 | 11 | |
| 127 | 172M USD | 8 | 41 | |
| 127 | 319M USD | 8 | 28 | |
| 127 | 255M USD | 8 | 36 | |
| 127 | 264M USD | 8 | 30 | |
| 127 | 255M USD | 8 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score